{"abstract": "Four years after purchasing Esperion Therapeutics, a company focused on the discovery and development of compounds for cardiovascular and metabolic disease, Pfizer is selling the Ann Arbor, Mich.-based firm to an entity funded by a group of investors.", "web_url": "https://dealbook.nytimes.com/2008/05/02/esperion-raises-228-million-after-pfizer-spin-out/", "snippet": "", "lead_paragraph": "Four years after purchasing Esperion Therapeutics, a company focused on the discovery and development of compounds for cardiovascular and metabolic disease, Pfizer is selling the Ann Arbor, Mich.-based firm to an entity funded by a group of investors.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Esperion Raises $22.8 Million After Pfizer Spin-Out", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-05-02T10:44:01+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f54f567a-73ea-53fe-8389-536067a13b80", "word_count": 100, "uri": "nyt://article/f54f567a-73ea-53fe-8389-536067a13b80"}